XML 58 R30.htm IDEA: XBRL DOCUMENT v3.25.0.1
Acquisitions and Divestitures (Tables)
 12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Schedule of Estimated Fair Value of the Consideration Transferred for IHS Markit / Liabilities Assumed In Conjunction With Acquisitions Businesses
The fair value of the consideration transferred for IHS Markit was approximately $43.5 billion as of the merger date, which consisted of the following:

(in millions, except for share and per share data)February 28, 2022
Number of shares IHS Markit issued and outstanding* 400,988,207 
Exchange ratio0.2838
Number of S&P Global common stock transferred to IHS Markit stockholders113,800,453 
Closing price per share of S&P Global common stock**$380.89 
Fair value of S&P Global common stock transferred IHS Markit stockholders$43,345 
Fair value of S&P Global replacement equity awards attributable to pre-combination service$191 
Total equity consideration$43,536 

*Excludes 25,219,470 IHS Markit shares held by the Markit Group Holdings Limited Employee Benefit Trust (“EBT”). The shares held by the EBT were converted in the merger into S&P Global shares at the exchange ratio of 0.2838 and will continue to be held by the trustee in the EBT.
**Based on S&P Global's closing stock price on February 25, 2022
Liabilities assumed in conjunction with our acquisitions are as follows:
(in millions)Year ended December 31,
 202420232022
Fair value of assets acquired$549 $399 54,944 
Equity transferred— — (43,536)
Cash (paid) acquired, net (305)(296)210 
Liabilities assumed$244 $103 $11,618 
Schedule of Allocation of Purchase Price The allocation of purchase price recorded for IHS Markit is as follows:
(in millions)February 28, 2022
Assets acquired
Cash and cash equivalents$310 
Accounts receivable, net968 
Prepaid and other current assets224 
Assets of businesses held for sale 1,519 
Property and equipment118 
Right of use assets240 
Goodwill31,456 
Other intangible assets18,620 
Equity investments in unconsolidated subsidiaries1,644 
Other non-current assets54 
Total assets acquired$55,153 
Liabilities assumed
Accounts payable$174 
Accrued compensation90 
Short-term debt968 
Unearned revenue1,053 
Other current liabilities581 
Liabilities of businesses held for sale72 
Long-term debt 4,191 
Lease liabilities - non-current231 
Deferred tax liability - non-current4,200 
Other non-current liabilities57 
Total liabilities assumed$11,617 
Total consideration transferred$43,536 
Schedule of Acquired Identifiable Intangible Assets
The following table sets forth the fair values of the components of the identifiable intangible assets acquired and their useful lives:
(in millions)February 28, 2022
Fair ValueWeighted Average Useful Lives
Customer relationships$13,596 25 years
Trade names and trademarks1,469 14 years
Developed technology1,043 10 years
Databases2,512 12 years
Total Identified Intangible Assets$18,620 21 years
Schedule of Pro Forma Information The pro forma results do not include anticipated synergies or other expected benefits of the acquisition.
Year ended
December 31,
(in millions)20222021
Revenue$11,842 $12,382 
Net income$3,533 $4,137 
Schedule of Key Components of Assets and Liabilities Held for Sale
The operating (loss) profit of our businesses that were held for sale or disposed of for the years ending December 31, 2024, 2023 and 2022 is as follows:
(in millions)Year ended December 31,
202420232022
Operating (loss) profit 1
$(1)$22 $82 
1 The operating (loss) profit presented includes the revenue and recurring direct expenses associated with businesses held for sale. The year ended December 31, 2024 excludes a pre-tax gain related to the sale of the PrimeOne business of $38 million and a pre-tax gain related to the sale of Fincentric of $21 million. The year ended December 31, 2023 excludes a pre-tax loss related to the sale of Engineering Solutions of $120 million. The year ended December 31, 2022 excludes pre-tax gains related to the sale LCD and a related family of leveraged loan indices of $505 million and $52 million, respectively. The year ended December 31, 2022 also excludes a pre-tax gain of $1.3 billion related to the sale of CGS.